Abstract:Abstract BACKGROUND The half-life of target proteins is frequently an important parameter in mechanistic pharmacokinetic and pharmacodynamic (PK/PD) modeling of biotherapeutics. Clinical studies for accurate measurement of physiologically relevant protein turnover can reduce the uncertainty in PK/PD model-based predictions, for example, of the therapeutic dose and dosing regimen in first-in-human clinical trials. METHODS We used a targeted mass spectrometry work flow based on serial immunoaffinity enrichment ofmultiple human serum proteins from a [5,5,5-2H3]-L-leucine tracer pulse-chase study in healthy volunteers. To confirm the reproducibility of turnover measurements from serial immunoaffinity enrichment, multiple aliquots from the same sample set were subjected to protein turnover analysis in varying order. Tracer incorporation was measured by multiple–reaction-monitoring mass spectrometry and target turnover was calculated using a four-compartment pharmacokinetic model. RESULTS Five proteins of clinical or therapeutic relevance including soluble tumor necrosis factor receptor superfamily member 12A, tissue factor pathway inhibitor, soluble interleukin 1 receptor like 1, soluble mucosal addressin cell adhesion molecule 1, and muscle-specific creatine kinase were sequentially subjected to turnover analysis from the same human serum sample. Calculated half-lives ranged from 5–15 h; however, no tracer incorporation was observed for mucosal addressin cell adhesion molecule 1. CONCLUSIONS The utility of clinical pulse-chase studies to investigate protein turnover can be extended by serial immunoaffinity enrichment of target proteins. Turnover analysis from serum and subsequently from remaining supernatants provided analytical sensitivity and reproducibility for multiple human target proteins in the same sample set, irrespective of the order of analysis.

Protein turnover rates in plant mitochondria.

Degradation Rate of Mitochondrial Proteins in Arabidopsis Thaliana Cells.

Quantitative Analysis of Protein Turnover in Plants.

Chloroplasts Protein Quality Control and Turnover: A Multitude of Mechanisms

Protein Degradation Rate in Arabidopsis Thaliana Leaf Growth and Development.

Improved determination of protein turnover rate with heavy water labeling by mass isotopomer ratio selection

Turnover rates of human muscle proteins in vivo reported in fractional, mole and absolute units

Dynamic 13c-Labeling Experiments Prove Important Differences In Protein Turnover Rate Between Two Saccharomyces Cerevisiae Strains

Multitagging Proteomic Strategy to Estimate Protein Turnover Rates in Dynamic Systems

Determining Degradation and Synthesis Rates of Arabidopsis Proteins Using the Kinetics of Progressive 15N Labeling of Two-dimensional Gel-separated Protein Spots

Quantifying label enrichment from two mass isotopomers increases proteome coverage for in vivo protein turnover using heavy water metabolic labeling

Kinetic profiling of metabolic specialists demonstrates stability and consistency of in vivo enzyme turnover numbers

Advances in Protein Turnover Analysis at the Global Level and Biological Insights

Derailed protein turnover in the aging mammalian brain

Subcellular protein turnover in human neural progenitor cells revealed by correlative electron microscopy and nanoscale secondary ion mass spectrometry imaging

Toward a hypothesis-free understanding of how phosphorylation dynamically impacts protein turnover

Protein Turnover Measurements in Human Serum by Serial Immunoaffinity LC-MS/MS

Elevated Temperature Effects on Protein Turnover Dynamics in Arabidopsis thaliana Seedlings Revealed by 15N-Stable Isotope Labeling and ProteinTurnover Algorithm

How do plants make mitochondria?

Identification of New Proteins and Potential Mitochondrial F<sub>1</sub>F<sub>0</sub>-ATPase Inhibitor Factor 1-Associated Mechanisms in <i>Arabidopsis thaliana</i> Using iTRAQ-Based Quantitative Proteomic Analysis

Assays to monitor mitochondrial translation